Hamaoka T - Search Results

1

Thymic stromal cells eliminate T cells stimulated with antigen plus stromal Ia molecules through their cross-talk involving the production of interferon-gamma and nitric oxide.

Tai XG, Saitoh Y, Satoh T, Yamamoto N, Kita Y, Takenaka H, Yu WG, Zou JP, Hamaoka T, Fujiwara H. Tai XG, et al. Among authors: hamaoka t. Thymus. 1994-1995;24(1):41-56. Thymus. 1994. PMID: 8629278

2

Proliferation and differentiation of immature thymocytes induced by a thymic stromal cell clone.

Fujiwara H, Ogata M, Mizushima Y, Tatsumi Y, Takai Y, Hamaoka T. Fujiwara H, et al. Among authors: hamaoka t. Thymus. 1990 Nov-Dec;16(3-4):159-72. Thymus. 1990. PMID: 2293420

3

Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden.

Zou JP, Nagata T, Yamamoto N, Ono S, Fujiwara H, Hamaoka T. Zou JP, et al. Among authors: hamaoka t. J Cancer Res Clin Oncol. 1994;120(5):279-85. doi: 10.1007/BF01236384. J Cancer Res Clin Oncol. 1994. PMID: 7907334

4

Thymic stroma-derived T-cell inhibitory factor (TSTIF). 2: TSTIF acts on the antigen-presenting cell to inhibit antigen-stimulated T-cell proliferation.

Tai XG, Kita Y, Toyooka K, Hamaoka T, Fujiwara H. Tai XG, et al. Among authors: hamaoka t. Thymus. 1993 Jun;21(4):247-58. Thymus. 1993. PMID: 8284807

5

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.

Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T. Zou JP, et al. Among authors: hamaoka t. Int Immunol. 1995 Jul;7(7):1135-45. doi: 10.1093/intimm/7.7.1135. Int Immunol. 1995. PMID: 8527411

6

CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism.

Toyooka K, Maruo S, Iwahori T, Yamamoto N, Tai XG, Abe R, Takahama Y, Murakami M, Uede T, Hamaoka T, Fujiwara H. Toyooka K, et al. Among authors: hamaoka t. Int Immunol. 1996 Feb;8(2):159-69. doi: 10.1093/intimm/8.2.159. Int Immunol. 1996. PMID: 8671600

7

Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.

Yu WG, Yamamoto N, Takenaka H, Mu J, Tai XG, Zou JP, Ogawa M, Tsutsui T, Wijesuriya R, Yoshida R, Herrmann S, Fujiwara H, Hamaoka T. Yu WG, et al. Among authors: hamaoka t. Int Immunol. 1996 Jun;8(6):855-65. doi: 10.1093/intimm/8.6.855. Int Immunol. 1996. PMID: 8671675

8

Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated double-positive thymocytes.

Tai XG, Toyo-oka K, Yamamoto N, Yashiro Y, Mu J, Hamaoka T, Fujiwara H. Tai XG, et al. Among authors: hamaoka t. J Immunol. 1997 May 15;158(10):4696-703. J Immunol. 1997. PMID: 9144482

9

Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.

Zou JP, Shimizu J, Ikegame K, Yamamoto N, Ono S, Fujiwara H, Hamaoka T. Zou JP, et al. Among authors: hamaoka t. J Immunol. 1992 Jan 15;148(2):648-55. J Immunol. 1992. PMID: 1345922

10

Identification of IL-7-dependent bone marrow-derived Thy-1-B220- lymphoid cell clones that rearrange and express both Ig and T cell receptor genes.

Takai Y, Sakata T, Iwagami S, Tai XG, Kita Y, Hamaoka T, Sakaguchi N, Yamagishi H, Tsuruta Y, Teraoka H, et al. Takai Y, et al. Among authors: hamaoka t. J Immunol. 1992 Mar 1;148(5):1329-37. J Immunol. 1992. PMID: 1347049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters